Recap: CytoSorbents Q4 Earnings

Comments
Loading...

CytoSorbents CTSO reported its Q4 earnings results on Thursday, March 14, 2024 at 04:15 PM.

Here's what investors need to know about the announcement.

Earnings

CytoSorbents beat estimated earnings by 14.000000000000002%, reporting an EPS of $-0.12 versus an estimate of $-0.14.

Revenue was down $691 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.09 which was followed by a 1.0% increase in the share price the next day.

Here's a look at CytoSorbents's past performance:

Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022
EPS Estimate -0.12 -0.11 -0.13 -0.17
EPS Actual -0.21 -0.14 -0.17 -0.01
Revenue Estimate 9.49M 11.03M 8.73M 8.72M
Revenue Actual 8.81M 9.42M 9.45M 9.39M

To track all earnings releases for CytoSorbents visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

CTSO Logo
CTSOCytoSorbents Corp
$0.9801-1.99%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum42.62
Growth76.13
Quality-
Value61.10
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In: